Plant-made vaccines in support of the Millennium Development Goals.
Vaccines are one of the most successful public health achievements of the last century. Systematic immunisation programs have reduced the burden of infectious diseases on a global scale. However, there are limitations to the current technology, which often requires costly infrastructure and long lead times for production. Furthermore, the requirement to keep vaccines within the cold-chain throughout manufacture, transport and storage is often impractical and prohibitively expensive in developing countries-the very regions where vaccines are most needed. In contrast, plant-made vaccines (PMVs) can be produced at a lower cost using basic greenhouse agricultural methods, and do not need to be kept within such narrow temperature ranges. This increases the feasibility of developing countries producing vaccines locally at a small-scale to target the specific needs of the region. Additionally, the ability of plant-production technologies to rapidly produce large quantities of strain-specific vaccine demonstrates their potential use in combating pandemics. PMVs are a proven technology that has the potential to play an important role in increasing global health, both in the context of the 2015 Millennium Development Goals and beyond.
Department of Biological Sciences, Monash University, Clayton, VIC, Australia. claire.penney@monash.edu
Claire A
CA
Penney
David R
DR
Thomas
Sadia S
SS
Deen
Amanda M
AM
Walmsley
D019149:Bioreactors; D003140:Communicable Disease Control; D003906:Developing Countries; D004356:Drug Storage / Q000379:methods / Q000592:standards; D005818:Genetic Engineering / Q000379:methods*; D006801:Humans; D010944:Plants / Q000235:genetics / Q000378:metabolism*; D030821:Plants, Genetically Modified; D055550:Protein Stability; D013678:Technology, Pharmaceutical / Q000379:methods / Q000639:trends*; D014612:Vaccines / Q000096:biosynthesis* / Q000191:economics / Q000235:genetics
D014612:Vaccines
Plant Physiol. 2008 Nov;148(3):1212-8
18775971
Expert Rev Vaccines. 2010 Aug;9(8):859-76
20673010
Annu Rev Entomol. 1999;44:51-75
9990716
Cell Mol Life Sci. 2003 Mar;60(3):433-45
12737305
Transgenic Res. 2005 Aug;14(4):449-62
16201411
Vaccine. 2004 Jun 23;22(19):2420-4
15193404
Plant Mol Biol. 2000 Mar;42(4):583-90
10809004
Plant Biotechnol J. 2010 Jun;8(5):525-8
20500680
Transgenic Res. 2002 Oct;11(5):479-93
12437079
Lancet. 2005 Jul 2-8;366(9479):44-9
15993232
Plant Physiol. 2010 Feb;152(2):622-33
20018596
Science. 2003 Nov 28;302(5650):1519-22
14645836
Lancet. 2006 Dec 23;368(9554):2211-8
17189032
Plant Biotechnol J. 2009 Dec;7(9):846-55
19781007
N Engl J Med. 2010 Jan 28;362(4):289-98
20107214
J Clin Microbiol. 1986 Oct;24(4):585-90
2429984
Vaccine. 2006 Mar 24;24(14):2477-90
16442673
Ann Oncol. 2010 Dec;21(12):2420-2427
20494963
Trends Biotechnol. 2006 Mar;24(3):109-14
16460821
Vaccine. 2003 Jan 30;21(7-8):803-8
12531364
Vaccine. 2006 Apr 24;24(17):3538-44
16519973
PLoS Med. 2008 Jan 15;5(1):e3
18198939
Ann Epidemiol. 2007 Mar;17(3):199-207
17174567
Vaccine. 2010 Jul 5;28(30):4709-12
20488262
Planta. 2010 Jul;232(2):409-16
20461403
Lancet. 2002 Jun 22;359(9324):2188-94
12090998
Bull World Health Organ. 2002;80(11):859-70
12481207
Vaccine. 2005 Mar 18;23(17-18):2042-8
15755568
Biotechnol Adv. 2009 Nov-Dec;27(6):1015-1022
19460423
Biotechnol Adv. 2010 Mar-Apr;28(2):214-21
19961918
Vaccine. 2003 May 1;21(16):1776-9
12686093
Proc Natl Acad Sci U S A. 2010 May 11;107(19):8794-9
20421480
Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):10986-91
17573530
Trends Biotechnol. 2010 Jan;28(1):37-45
19897265
Adv Drug Deliv Rev. 2006 Apr 20;58(1):68-89
16564111
Biotechnol Adv. 2009 Nov-Dec;27(6):811-832
19576278
Plant Biotechnol J. 2006 Jul;4(4):419-32
17177807
Vaccine. 2009 Jul 30;27(35):4798-807
19539581
Biotechnol Adv. 2007 Mar-Apr;25(2):203-6
17196782
J Infect Dis. 2009 Sep 15;200(6):835-7
19673653
Nat Biotechnol. 2005 Jun;23(6):718-23
15883585
Methods. 2006 Sep;40(1):60-5
16997714
East Afr Med J. 2000 Sep;77(9):476-9
12862137
Glob Public Health. 2009;4(4):323-37
19579068
Proc Natl Acad Sci U S A. 2004 May 4;101(18):6852-7
15103020
Immunol Rev. 2005 Aug;206:232-59
16048553
Plant Biotechnol J. 2007 Sep;5(5):555-69
17645439
Plant Mol Biol. 1998 Sep;38(1-2):77-99
9738961
Immunol Cell Biol. 2005 Jun;83(3):248-56
15877602
Plant Biotechnol J. 2007 Jan;5(1):50-9
17207256
PLoS One. 2010 Sep 27;5(9):e12986
20885995
Vaccine. 2006 Sep 29;24(40-41):6367-70
17240560
Science. 2010 Sep 17;329(5998):1462-3
20847246
Eur J Health Econ. 2008 Feb;9(1):7-15
17333089
J Biol Stand. 1980;8(4):281-7
7009615
Curr Opin Plant Biol. 2004 Apr;7(2):152-8
15003215
Vaccine. 2007 Sep 28;25(39-40):6852-62
17719149
Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):6998-7002
17420459
Vaccine. 2006 Jul 26;24(31-32):5787-99
16759763
J Immunol. 1993 Nov 15;151(10):5751-61
7693817
MMWR Recomm Rep. 2002 Feb 8;51(RR-2):1-35
11848294
CMAJ. 2004 Oct 26;171(9):1050
15505266
Adv Drug Deliv Rev. 2005 Jun 17;57(9):1247-65
15935873
Mol Biotechnol. 2002 Jan;20(1):29-40
11876297
Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11709-12
19597152
Lancet Infect Dis. 2004 Dec;4(12):719
15593445
Expert Rev Vaccines. 2010 Aug;9(8):971-82
20673018
Trends Plant Sci. 2009 Dec;14(12):669-79
19836291
Vaccine. 2010 Feb 3;28(5):1156-67
20004635
Eur J Epidemiol. 1994 Aug;10(4):451-3
7843353
Plant Biotechnol J. 2008 Dec;6(9):930-40
19076615
Expert Rev Mol Med. 2010 Apr 29;12:e14
20426889
Pharm Res. 2010 Oct;27(10):2040-2
20467887
Plant Biotechnol J. 2010 Jun;8(5):607-19
20199612
Infect Immun. 2005 Dec;73(12):8266-74
16299323
Vaccine. 2007 Jan 8;25(4):691-7
16968657
J Public Health Policy. 2007;28(3):322-40
17717543
Plant Cell Rep. 2003 Jun;21(10):1020-6
12835913